Featured
How to connect patients with rare diseases to clinical trials
Rare disease clinical research is no longer an afterthought for pharmaceutical companies with rapid approvals and increased investment in this…
UK rejoins EU’s Horizon Europe science programme
The UK has re-joined the EU’s Horizon Europe science research programme after the country’s post-Brexit absence and long-stalled talks. British…
UK life sciences grapple with the job market’s digital dilemma
Despite a cautious outlook at the beginning of 2023, the latest data from the Office for National Statistics (ONS) suggests…
Thermo Fisher completes $912.5m acquisition of CorEvitas
Thermo Fisher Scientific has completed its acquisition of data intelligence company CorEvitas for $912.5m in cash. Thermo Fisher first announced…
FDA greenlights first OTC topical gel for erectile dysfunction
Patients with erectile dysfunction (ED) will now be able to access a topical treatment without the need for a prescription…
FDA issues alert for health care providers after oxygenator device recall
The US Food and Drug Administration (FDA) has issued a press release providing recommendations on how to handle the recent…
Study posits allergen exposure chamber to trial allergen immunotherapy
Researchers from the ALL-MED Medical Research Institute and the Department of Clinical Immunology at Wroclaw Medical University in Poland have…
Beta Bionics’ automated insulin delivery system picks up manufacturing partner
Chronic disease tech company Convatec Group has partnered with Beta Bionics to manufacture the insulin delivery system iLet Bionic Pancrease.…
Tapping into digital therapeutics to improve neurological outcomes
As the field of digital therapeutics continues to broaden, specific uses in mental health and neurology are increasingly making headway…
One Medical CEO rebuts Amazon data privacy concerns
The recently closed Amazon-One Medical acquisition focuses on a “longitudinal relationship” with individual members and has nothing to do with…